{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T17:43:46Z","timestamp":1790617426515,"version":"4.1.0"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Thomas H Maren Foundation"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Respiratory Physiology & Neurobiology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.resp.2017.07.005","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T14:47:15Z","timestamp":1500130035000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"special_numbering":"C","title":["Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge\u2019s disease)"],"prefix":"10.1016","volume":"246","author":[{"given":"Shailendra","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Gralla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joyce Gonzalez","family":"Ordonez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Elena","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik R.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Schoene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackeline Pando","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Callacondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rivard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Roncal-Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Fuquay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian P.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai E.","family":"Swenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdias","family":"Hurtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Escudero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.resp.2017.07.005_bib0005","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/0002-9343(72)90136-2","article-title":"Cobalt-beer cardiomyopathy. A clinical and pathologic study of twenty-eight cases","volume":"53","author":"Alexander","year":"1972","journal-title":"Am. J. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0010","first-page":"446","article-title":"Higher erythropoietin secretion in response to cobaltous chloride in post-hypoxic than in hypertransfused polycythemic mice","volume":"77","author":"Alippi","year":"1992","journal-title":"Haematologica"},{"key":"10.1016\/j.resp.2017.07.005_bib0015","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1159\/000354515","article-title":"Hypoxia-inducible factor-1alpha dependent pathways mediate the renoprotective role of acetazolamide against renal ischemia-reperfusion injury","volume":"32","author":"An","year":"2013","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.resp.2017.07.005_bib0020","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1378\/chest.12-0728","article-title":"Oxidative-nitrosative stress and systemic vascular function in highlanders with and without exaggerated hypoxemia","volume":"143","author":"Bailey","year":"2013","journal-title":"Chest"},{"key":"10.1016\/j.resp.2017.07.005_bib0025","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1093\/jn\/117.6.1003","article-title":"Pharmacologic role of cysteine in ameliorating or exacerbating mineral toxicities","volume":"117","author":"Baker","year":"1987","journal-title":"J. Nutr."},{"key":"10.1016\/j.resp.2017.07.005_bib0030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/icb\/icj004","article-title":"Andean, Tibetan, and Ethiopian patterns of adaptation to high-altitude hypoxia","volume":"46","author":"Beall","year":"2006","journal-title":"Integr. Comp. Biol."},{"key":"10.1016\/j.resp.2017.07.005_bib0035","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1445-5994.1975.tb03263.x","article-title":"Cobalt chloride in the treatment of refractory anaemia in patients undergoing long-term haemodialysis","volume":"5","author":"Bowie","year":"1975","journal-title":"Aust. N. Z. J. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0040","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/978-1-4613-8850-0_3","article-title":"Cobalt in the environment and its toxicological implications","volume":"108","author":"Domingo","year":"1989","journal-title":"Rev. Environ. Contam. Toxicol."},{"key":"10.1016\/j.resp.2017.07.005_bib0045","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1080\/10937404.2012.744287","article-title":"Dose-response relationships for blood cobalt concentrations and health effects: a review of the literature and application of a biokinetic model","volume":"15","author":"Finley","year":"2012","journal-title":"J. Toxicol. Environ. Health B Crit. Rev."},{"key":"10.1016\/j.resp.2017.07.005_bib0050","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1046\/j.1365-201x.2002.00946.x","article-title":"Influence of controlled hypoxia and radical scavenging agents on erythropoietin and malondialdehyde concentrations in humans","volume":"174","author":"Freudenthaler","year":"2002","journal-title":"Acta Physiol. Scand."},{"key":"10.1016\/j.resp.2017.07.005_bib0055","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0954-6111(98)90506-6","article-title":"Characterization of N-acetylcysteine and ambroxol in anti-oxidant therapy","volume":"92","author":"Gillissen","year":"1998","journal-title":"Respir. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0060","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/0002-9343(58)90087-1","article-title":"A case of chronic mountain sickness in the United States: clinical, physiologic and electrocardiographic observations","volume":"25","author":"Hecht","year":"1958","journal-title":"Am. J. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0065","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1182\/blood.V99.5.1552","article-title":"Effect of N-acetyl-cysteine on the hypoxic ventilatory response and erythropoietin production: linkage between plasma thiol redox state and O(2) chemosensitivity","volume":"99","author":"Hildebrandt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.resp.2017.07.005_bib0070","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1126\/science.1059796","article-title":"Targeting of HIF-alpha to the von Hippel-Lindau ubiquitylation complex by O2-regulated prolyl hydroxylation","volume":"292","author":"Jaakkola","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.resp.2017.07.005_bib0075","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/ajkd.2002.33380","article-title":"Hyperuricemia, hypertension, and proteinuria associated with high-altitude polycythemia","volume":"39","author":"Jefferson","year":"2002","journal-title":"Am. J. Kidney Dis."},{"key":"10.1016\/j.resp.2017.07.005_bib0080","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(02)07594-3","article-title":"Excessive erythrocytosis, chronic mountain sickness, and serum cobalt levels","volume":"359","author":"Jefferson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2017.07.005_bib0085","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1089\/152702904322963690","article-title":"Increased oxidative stress following acute and chronic high altitude exposure","volume":"5","author":"Jefferson","year":"2004","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.resp.2017.07.005_bib0090","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/978-1-4615-4711-2_27","article-title":"International consensus group on chronic mountain sickness","volume":"474","author":"Leon-Velarde","year":"1999","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.resp.2017.07.005_bib0095","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.freeradbiomed.2013.05.024","article-title":"Nrf2 activation: a potential strategy for the prevention of acute mountain sickness","volume":"63","author":"Lisk","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0100","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00297121","article-title":"Comparison of the effectiveness of several chelators after single administration on the toxicity, excretion and distribution of cobalt","volume":"58","author":"Llobet","year":"1986","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.resp.2017.07.005_bib0105","first-page":"225","article-title":"Comparative effects of repeated paretneral administration of several chelators on the distribution and excretion of cobalt","volume":"60","author":"Llobet","year":"1988","journal-title":"Res. Commun. Chem. Pathol. Pharmacol."},{"key":"10.1016\/j.resp.2017.07.005_bib0110","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.freeradbiomed.2013.06.028","article-title":"Role of direct reactivity with metals in chemoprotection by N-acetylcysteine against chromium(VI), cadmium(II), and cobalt(II)","volume":"65","author":"Luczak","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0115","series-title":"High-altitude Diseases: Mechanism and Management","author":"Monge","year":"1966"},{"issue":"Suppl","key":"10.1016\/j.resp.2017.07.005_bib0120","first-page":"87","article-title":"Chronic mountain sickness","volume":"139","author":"Monge","year":"1976","journal-title":"Johns Hopkins Med. J."},{"issue":"Suppl. 1","key":"10.1016\/j.resp.2017.07.005_bib0125","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1055\/s-2007-1024603","article-title":"Pathophysiology and epidemiology of chronic mountain sickness","volume":"13","author":"Monge","year":"1992","journal-title":"Int. J. Sports Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0130","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1126\/science.95.2456.79","article-title":"Life in the andes and chronic mountain sickness","volume":"95","author":"Monge","year":"1942","journal-title":"Science"},{"key":"10.1016\/j.resp.2017.07.005_bib0135","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1089\/152702901750265341","article-title":"Human genetic adaptation to high altitude","volume":"2","author":"Moore","year":"2001","journal-title":"High Alt. Med. Biol."},{"key":"10.1016\/j.resp.2017.07.005_bib0140","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3109\/10408444.2013.779633","article-title":"A review of the health hazards posed by cobalt","volume":"43","author":"Paustenbach","year":"2013","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.resp.2017.07.005_bib0145","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0140-6736(02)07812-1","article-title":"Angiotensin-converting-enzyme inhibition therapy in altitude polycythaemia: a prospective randomised trial","volume":"359","author":"Plata","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.resp.2017.07.005_bib0150","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.freeradbiomed.2009.01.016","article-title":"Evaluation of new thiadiazoles and benzothiazoles as potential radioprotectors: free radical scavenging activity in vitro and theoretical studies (QSAR, DFT)","volume":"46","author":"Prouillac","year":"2009","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0155","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1164\/rccm.200505-807OC","article-title":"Acetazolamide: a treatment for chronic mountain sickness","volume":"172","author":"Richalet","year":"2005","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0160","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1164\/rccm.200802-196OC","article-title":"Acetazolamide for Monge\u2019s disease: efficiency and tolerance of 6-month treatment","volume":"177","author":"Richalet","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.resp.2017.07.005_bib0165","doi-asserted-by":"crossref","first-page":"40337","DOI":"10.1074\/jbc.M403057200","article-title":"Depletion of intracellular ascorbate by the carcinogenic metals nickel and cobalt results in the induction of hypoxic stress","volume":"279","author":"Salnikow","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.resp.2017.07.005_bib0170","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1152\/japplphysiol.01407.2006","article-title":"Prevention of acute mountain sickness by acetazolamide: as yet an unfinished story","volume":"102","author":"Swenson","year":"2007","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.resp.2017.07.005_bib0175","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1152\/japplphysiol.00443.2015","article-title":"Pharmacology of acute mountain sickness: old drugs and newer thinking","volume":"120","author":"Swenson","year":"1985","journal-title":"J. Appl. Physiol."},{"key":"10.1016\/j.resp.2017.07.005_bib0180","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.RES.17.1.30","article-title":"Polycythemia and right ventricular hypertrophy","volume":"17","author":"Swigart","year":"1965","journal-title":"Circ. Res."},{"key":"10.1016\/j.resp.2017.07.005_bib0185","series-title":"Hypoxia, Polycythemia, and Chronic Mountain Sickness","author":"Winslow","year":"1987"},{"key":"10.1016\/j.resp.2017.07.005_bib0190","series-title":"Progress in Mountain Medicine and High Altitude Physiology","first-page":"120","article-title":"Epidemiology of chronic mountain sickness: ten years study in Quingai\u2014Tibet","author":"Wu","year":"1998"},{"key":"10.1016\/j.resp.2017.07.005_bib0195","first-page":"161","article-title":"Chronic mountain sickness on the Qinghai-Tibetan plateau","volume":"118","author":"Wu","year":"2005","journal-title":"Chin. Med. J. (Engl.)"},{"key":"10.1016\/j.resp.2017.07.005_bib0200","doi-asserted-by":"crossref","first-page":"e2342","DOI":"10.1371\/journal.pone.0002342","article-title":"Adaptation and mal-adaptation to ambient hypoxia; Andean, Ethiopian and Himalayan patterns","volume":"3","author":"Xing","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.resp.2017.07.005_bib0205","doi-asserted-by":"crossref","first-page":"855","DOI":"10.33549\/physiolres.931590","article-title":"The comparison of antioxidant and hematological properties of N-acetylcysteine and alpha-lipoic acid in physically active males","volume":"58","author":"Zembron-Lacny","year":"2009","journal-title":"Physiol. Res."}],"container-title":["Respiratory Physiology & Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904817300873?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569904817300873?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T22:38:21Z","timestamp":1761604701000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569904817300873"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":41,"alternative-id":["S1569904817300873"],"URL":"https:\/\/doi.org\/10.1016\/j.resp.2017.07.005","relation":{},"ISSN":["1569-9048"],"issn-type":[{"value":"1569-9048","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acetazolamide and N-acetylcysteine in the treatment of chronic mountain sickness (Monge\u2019s disease)","name":"articletitle","label":"Article Title"},{"value":"Respiratory Physiology & Neurobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.resp.2017.07.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}